These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 24447179)

  • 21. Cutaneous carcinoma with mixed histology.
    Huang CC
    South Med J; 2005 Jul; 98(7):680. PubMed ID: 16108234
    [No Abstract]   [Full Text] [Related]  

  • 22. Epiluminescence microscopy (dermoscopy) versus visual inspection during Mohs microscopic surgery of infiltrative basal cell carcinoma.
    Gurgen J; Gatti M
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):1066-9. PubMed ID: 22676346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Squamous cell carcinoma of the skin.
    Frankel DH
    Hosp Pract (Off Ed); 1992 Feb; 27(2A):99-102, 105-6. PubMed ID: 1737826
    [No Abstract]   [Full Text] [Related]  

  • 24. Mohs micrographic surgery: a synopsis.
    Stone JL
    Hawaii Med J; 1993 May; 52(5):134-9. PubMed ID: 8320092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular papillary endothelial hyperplasia presenting in a Mohs surgical scar.
    Vélez NF; Sweeney SM; OʼLeary E; Jellinek NJ
    Dermatol Surg; 2014 Dec; 40(12):1444-6. PubMed ID: 25365358
    [No Abstract]   [Full Text] [Related]  

  • 26. Repair of basal cell carcinoma on the outer canthus via a bifurcated island flap.
    Wu X; Qian G; Fang F
    Dermatol Surg; 2006 Nov; 32(11):1421-3. PubMed ID: 17083600
    [No Abstract]   [Full Text] [Related]  

  • 27. Axillary basal cell carcinoma.
    Woo SH; Kim IH; Son SW
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):222-3. PubMed ID: 16441641
    [No Abstract]   [Full Text] [Related]  

  • 28. Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee.
    Leitenberger JJ; Rogers H; Chapman JC; Maher IA; Fox MC; Harmon CB; Bailey EC; Odland P; Wysong A; Johnson T; Wisco OJ
    J Am Acad Dermatol; 2016 Nov; 75(5):1022-1031. PubMed ID: 27546292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difficult to diagnose skin cancer--the 'aggressive' BCC.
    Tomas S
    Aust Fam Physician; 2009 Jul; 38(7):492-7. PubMed ID: 19575067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Accuracy of Self-Reported Skin Cancer Diagnosis: Room for Improvement.
    Sommer LL; Eminger LA; Lawrence N
    Dermatol Surg; 2016 Sep; 42(9):1110-1. PubMed ID: 27564083
    [No Abstract]   [Full Text] [Related]  

  • 31. Diagnostic accuracy of dermatoscopy for melanocytic and nonmelanocytic pigmented lesions.
    Rosendahl C; Tschandl P; Cameron A; Kittler H
    J Am Acad Dermatol; 2011 Jun; 64(6):1068-73. PubMed ID: 21440329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery.
    Alcalay J; Alkalay R; Hazaz B
    Int J Dermatol; 2004 Jun; 43(6):456-8. PubMed ID: 15186232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reliability of skin biopsies in determining accurate tumor margins: a retrospective study after Mohs micrographic surgery.
    Koslosky CL; El Tal AK; Workman B; Tamim H; Durance MC; Mehregan DA
    Dermatol Surg; 2014 Sep; 40(9):964-70. PubMed ID: 25099294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mohs micrographic surgery for facial skin cancer.
    Jones NS
    Arch Facial Plast Surg; 2002; 4(2):125. PubMed ID: 12020214
    [No Abstract]   [Full Text] [Related]  

  • 35. Pseudo positive, pseudo positive negative, pseudo positive positive negative, and pseudo pseudo positive positive negative positive margins in dermatopathology.
    Lee B; Lambert MW; Bhate C; Kamelgard J; Lambert WC
    Skinmed; 2013; 11(1):46-7. PubMed ID: 23540077
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of dermoscopy in Mohs micrographic surgery (MMS) for nonmelanoma skin cancer (NMSC).
    Yeom SD; Lee SH; Ko HS; Chung KY; Shin J; Choi GS; Byun JW
    Int J Dermatol; 2017 Jun; 56(6):e136-e139. PubMed ID: 28247925
    [No Abstract]   [Full Text] [Related]  

  • 37. Pre-surgical basal cell carcinoma margin definition: the SMART approach.
    Gualdi G; Venturini M; Zanca A; Calzavara-Pinton PG; Pellacani G
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):474-6. PubMed ID: 25413728
    [No Abstract]   [Full Text] [Related]  

  • 38. Association Between Mohs Surgery Wait Times and Surgical Defect Size in Patients With Squamous Cell or Basal Cell Carcinoma of the Skin.
    Diehl J; Choi YM; Liang LJ; Chiu M
    Dermatol Surg; 2015 Jul; 41(7):768-74. PubMed ID: 26050214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upstaging of basal cell and squamous cell carcinomas during definitive surgery: a review of predictive preoperative clinical and histologic features.
    Clements S; Khachemoune A
    Arch Dermatol Res; 2021 Jul; 313(5):319-325. PubMed ID: 33108525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dermoscopy prior to Mohs micrographic surgery does not improve tumour margin assessment and leads to fewer Mohs stages.
    Jayasekera PSA; Dodd J; Oliphant T; Langtry JAA; Lawrence CM
    Br J Dermatol; 2018 Feb; 178(2):565-566. PubMed ID: 28851098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.